Details for New Drug Application (NDA): 050443
✉ Email this page to a colleague
NDA 050443 describes BLENOXANE, which is a drug marketed by Bristol Myers Squibb and is included in one NDA. Additional details are available on the BLENOXANE profile page.
The generic ingredient in BLENOXANE is bleomycin sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.
The generic ingredient in BLENOXANE is bleomycin sulfate. There are six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the bleomycin sulfate profile page.
Summary for 050443
| Tradename: | BLENOXANE |
| Applicant: | Bristol Myers Squibb |
| Ingredient: | bleomycin sulfate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050443
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 15 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 30 UNITS BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Sep 7, 1995 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
